| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/16/2010 | WO2010104923A1 Low molecular weight cyclin e (lmw-e) as a biomarker for personalization of cancer therapies |
| 09/16/2010 | WO2010104856A2 Devices and methods for contactless dielectrophoresis for cell or particle manipulation |
| 09/16/2010 | WO2010104815A1 Antibodies binding to pivka-ii amino acids 13-27 |
| 09/16/2010 | WO2010104768A1 Method and system for temperature correction in thermal melt analysis |
| 09/16/2010 | WO2010104761A2 Anti-cd40 antibodies and uses thereof |
| 09/16/2010 | WO2010104683A1 Immunoassays employing non-particulate chemiluminescent reagent |
| 09/16/2010 | WO2010104662A1 Protein markers identification for gastric cancer diagnosis |
| 09/16/2010 | WO2010104539A1 Methods of subclassification of ductal carcinoma of the breast |
| 09/16/2010 | WO2010104533A2 Automated method for detecting cancers and high grade hyperplasias |
| 09/16/2010 | WO2010104497A1 Analyzer and method for sensing using the same |
| 09/16/2010 | WO2010104479A1 Electrical sensor for ultrasensitive nucleic acid detection |
| 09/16/2010 | WO2010104478A1 Apparatus for processing a biological and/or chemical sample |
| 09/16/2010 | WO2010104294A2 Apparatus for monitoring a dye solution to be adsorbed to a dye-sensitized solar cell, and apparatus for adjusting the dye solution |
| 09/16/2010 | WO2010104292A2 Strobo thin film chemical analysis apparatus and assay method using the same |
| 09/16/2010 | WO2010104245A1 Antibody specific to methicillin resistant staphylococcus aureus, detection method and kit for methicillin resistant staphylococcus aureus using the same |
| 09/16/2010 | WO2010104225A1 Automatic urine analysis system and device thereof |
| 09/16/2010 | WO2010104223A1 Urine collecting device |
| 09/16/2010 | WO2010104208A1 Generation, expression and characterization of the humanized k33n monoclonal antibody |
| 09/16/2010 | WO2010104180A1 Method for measuring biogenous biologically active substances, a program for implementing the same, and apparatus for measuring biogenous biologically active substances |
| 09/16/2010 | WO2010104168A1 Blood cap2 level measurement method, liver disease detection method, and detection kit for measurement of blood cap2 level |
| 09/16/2010 | WO2010104035A1 Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer |
| 09/16/2010 | WO2010104025A1 Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases |
| 09/16/2010 | WO2010103828A1 Method of determining dilatation of coal, method of estimating specific volume of coal, method of determining degree of space filling, and method of coal blending |
| 09/16/2010 | WO2010103585A1 Method for evaluating metabolic syndrome or constituent disease thereof |
| 09/16/2010 | WO2010103583A1 Kit for detecting highly pathogenic avian influenza virus subtype h5n1 |
| 09/16/2010 | WO2010103526A1 Methods and systems of imaging cut stones |
| 09/16/2010 | WO2010103515A2 Compositions and methods for prevention and treatment of neurodegenerative diseases |
| 09/16/2010 | WO2010103350A1 A method for predicting the responsiveness to an anti-tnf alpha antibody treatment |
| 09/16/2010 | WO2010103308A2 Optical cell assembly, cartridge and apparatus |
| 09/16/2010 | WO2010103294A1 Modulation of t-cell mediated immune responses |
| 09/16/2010 | WO2010103136A1 Optimised method for the expression of recombinant proteins in insect larvae |
| 09/16/2010 | WO2010103111A1 Method for avian sex determination |
| 09/16/2010 | WO2010103058A1 Method or system using biomarkers for the monitoring of a treatment |
| 09/16/2010 | WO2010103056A1 Improvement of tumour treatment |
| 09/16/2010 | WO2010103053A1 Method and means for detecting the activity of osteoclasts |
| 09/16/2010 | WO2010103025A1 New method for detecting antimalarial drugs |
| 09/16/2010 | WO2010102412A1 Compositions and methods for characterizing arthritic conditions |
| 09/16/2010 | WO2010102387A1 Interleukin-12 polymorphisms for identifying risk for primary biliary cirrhosis |
| 09/16/2010 | WO2010088411A3 Conformationally dynamic peptides |
| 09/16/2010 | WO2010085548A3 Single molecule proteomics with dynamic probes |
| 09/16/2010 | WO2010079479A3 A multiple testing apparatus and method |
| 09/16/2010 | WO2010079428A3 Biomarkers for appetite regulation |
| 09/16/2010 | WO2010079339A3 Factors |
| 09/16/2010 | WO2010078872A3 Enrichment and identification of fetal cells in maternal blood and ligands for such use |
| 09/16/2010 | WO2010078376A3 Fc-specific polymer-conjugated antibodies and their diagnostic use |
| 09/16/2010 | WO2010075333A3 Organic chemical sensor with microporous organosilicate material |
| 09/16/2010 | WO2010075026A3 Methods for determining efficacy of a therapeutic regimen against deleterious effects of cytotoxic agents in human |
| 09/16/2010 | WO2010065544A3 Diagnostic and treatment methods for cancer based on immune inhibitors |
| 09/16/2010 | WO2010065536A3 Recombinant bone marrow stromal antigen-2 in the treatment of autoimmune diseases |
| 09/16/2010 | WO2010064435A8 Method for measuring cystatin c in human body fluid |
| 09/16/2010 | WO2010063783A3 Modulating xrn2 |
| 09/16/2010 | WO2010062683A3 Structure for molecular separations |
| 09/16/2010 | WO2010062650A3 Neamine compositions and methods of use thereof |
| 09/16/2010 | WO2010055510A3 Diagnosis of multiple sclerosis |
| 09/16/2010 | WO2010054377A3 Fully human antibodies against n-cadherin |
| 09/16/2010 | WO2010054221A3 Treatment of chronic inflammatory respiratory disorders |
| 09/16/2010 | WO2010046844A4 Method and device for assessing the structural characteristics of installed supporting poles |
| 09/16/2010 | WO2010039224A3 Respiratory syncytial virus (rsv) sequences for protein expression and vaccines |
| 09/16/2010 | US20100235930 Methods of selecting host resistant animals |
| 09/16/2010 | US20100235927 Non-human animal model for lung carcinoma |
| 09/16/2010 | US20100235926 Hairless Transgenic Animal |
| 09/16/2010 | US20100235107 Concentration sensor device and concentration detecting method |
| 09/16/2010 | US20100235106 Systems and methods for replacing signal artifacts in a glucose sensor data stream |
| 09/16/2010 | US20100235103 Method and apparatus for evaluating prothrombotic conditions |
| 09/16/2010 | US20100234796 System and methods for processing analyte sensor data |
| 09/16/2010 | US20100234528 Supports for oligomer synthesis |
| 09/16/2010 | US20100234463 Method for Identifying Modulators of Gamma Secretase or Notch |
| 09/16/2010 | US20100234417 Thyrotropin releasing hormone receptor-orexin receptor hetero-dimers/-oligomers |
| 09/16/2010 | US20100234407 Preventives/remedies for myeloma tumor and method for diagnosing the same |
| 09/16/2010 | US20100234381 Biomarkers and methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators |
| 09/16/2010 | US20100234344 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators |
| 09/16/2010 | US20100234303 Agents, methods and uses |
| 09/16/2010 | US20100234302 Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| 09/16/2010 | US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234276 Erythropoietin solution preparation |
| 09/16/2010 | US20100234274 Use of Nestafin-1 in the Treatment for Diabetes |
| 09/16/2010 | US20100234239 Methods and compositions for identifying, classifying and monitoring subject having bcl-2 family inhibitor-resistant tumors and cancers |
| 09/16/2010 | US20100233828 Site Selectively Tagged and Templated Molecularly Imprinted Polymers for Sensor Applications |
| 09/16/2010 | US20100233827 Method for producing molecule immobilizing substrate, and molecule immobilizing substrate |
| 09/16/2010 | US20100233826 Analytical composition and method |
| 09/16/2010 | US20100233825 Chemical sensor element, sensing apparatus, and sensing method |
| 09/16/2010 | US20100233824 Microfluidic methods and systems for use in detecting analytes |
| 09/16/2010 | US20100233823 Apparatus and method for ozonation of fluids |
| 09/16/2010 | US20100233820 Multipurpose analysis using second harmonic generating nanoprobes |
| 09/16/2010 | US20100233819 Robo: a novel family of polypeptides and nucleic acids |
| 09/16/2010 | US20100233818 Biological Load Indicator and Method of Measuring Biological Load |
| 09/16/2010 | US20100233817 Optical element, liquid crystal display device member with the optical element, liquid crystal display device with the liquid crystal display device member, method of producing the optical element and method of evaluating birefringence functional layer |
| 09/16/2010 | US20100233815 Methods for the Development of a Biomolecule Assay |
| 09/16/2010 | US20100233756 Animal Feed Kibble with Protein-Based Core and Related Methods |
| 09/16/2010 | US20100233742 Method of Quantifying Autoinducer-2 |
| 09/16/2010 | US20100233741 Immuno-based retargeted endopeptidase activity assays |
| 09/16/2010 | US20100233740 Use of urinary ngal to distinguish kidney disease and predict mortality in subjects with cirrhosis |
| 09/16/2010 | US20100233739 Use of urinary ngal to diagnose unilateral and bilateral urinary obstruction |
| 09/16/2010 | US20100233738 Urine pretreatment agent for urinary protein quantitation, urine pretreatment method, and urinary protein quantitation method |
| 09/16/2010 | US20100233737 Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker |
| 09/16/2010 | US20100233736 Detection method and kit |
| 09/16/2010 | US20100233735 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 09/16/2010 | US20100233734 Passivation of surfaces after ligand coupling |
| 09/16/2010 | US20100233733 Multiple mechanisms for modulation of the pi3 kinase pathway |